Infantile Hemangiomas

MIAMI BEACH, Fla. — From diagnosis to treatment, a speaker at the Masters of Pediatric Dermatology conference discussed updates for treating vascular birth marks in infants.

Preterm infants more often presented with infantile hemangiomas that were thicker with steeper borders compared with term infants, signaling a need for improved treatment, according to a study.

Initiating infantile hemangioma treatment with propranolol 2 mg/kg per day did not yield more adverse events than 1 mg/kg per day, according to a study.

Infants with infantile hemangiomas of the anogenital region were more likely to have an associated congenital anomaly compared with the general population, according to a study.

Topical 0.5% timolol maleate hydrogel may be a better alternative to oral propranolol in the treatment of infantile hemangiomas, according to a study.

The maxillary and mandibular segment borders of facial infantile hemangiomas were redefined after a review of more than 500 case-patients’ photographs, according to a study.

Patients with infantile hemangiomas often have a higher occurrence of other birthmarks, and this should be studied to determine any relationships, according to a letter published in the Journal of the American Academy of Dermatology.

Facial infantile hemangiomas at multiple sites may put infants at risk for posterior fossa malformations, hemangiomas, arterial anomalies, cardiac defects and eye anomalies, known as PHACE syndrome, according to a study.

Topical timolol, while well tolerated, offered little efficacy in treating early proliferative infantile hemangioma, according to a study.

Infants who have at least five infantile hemangiomas should be screened for infantile hepatic hemangioma, according to a study published in Journal of the American Academy of Dermatology.